SEC Form 4 · accession 0001624044-17-000001
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher L Gaenzle
Officer — CAO, GC & Sec
Period of report
Jan 3, 2017
Accepted (ET)
Jan 4, 2017 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jan 3, 2017 | M | 5,917 | $16.06 | A | 47,217 | D | |
| Class A Common StockF2 | Jan 3, 2017 | S | 5,817 | $51.902 | D | 41,400 | D | |
| Class A Common Stock | Jan 3, 2017 | S | 100 | $52.25 | D | 41,300 | D | |
| Class A Common Stock | Jan 3, 2017 | M | 4,733 | $10.06 | A | 46,033 | D | |
| Class A Common StockF3 | Jan 3, 2017 | S | 4,733 | $51.892 | D | 41,300 | D | |
| Class A Common Stock | Jan 3, 2017 | M | 4,733 | $10.57 | A | 46,033 | D | |
| Class A Common StockF4 | Jan 3, 2017 | S | 4,733 | $51.907 | D | 41,300 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F5 | $16.06 | Jan 3, 2017 | M | 5,917 | D | — | Jun 30, 2024 | Class A Common Stock | 5,917 | 29,585 | D |
| Stock Option (Right to Buy Class A Common Stock)F6 | $10.06 | Jan 3, 2017 | M | 4,733 | D | — | Aug 18, 2023 | Class A Common Stock | 4,733 | 14,200 | D |
| Stock Option (Right to Buy Class A Common Stock)F7 | $10.57 | Jan 3, 2017 | M | 4,733 | D | — | Apr 2, 2022 | Class A Common Stock | 4,733 | 9,466 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2016.
- F2The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $51.25 to $52.20, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- F3The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $51.50 to $52.15, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F4The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $51.50 to $52.35, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F5One half of the shares subject to this option vest yearly in five equal installments beginning on June 30, 2015, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2014, subject to continued employment.
- F6One half of the shares subject to this option vest yearly in five equal installments beginning on August 18, 2014, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.
- F7One half of the shares subject to this option vest yearly in five equal installments beginning on April 2, 2013, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.